Suppr超能文献

基于富集优化算法(EOA)与基于对接的虚拟筛选比较。

A Comparison between Enrichment Optimization Algorithm (EOA)-Based and Docking-Based Virtual Screening.

机构信息

Department of Chemistry, Bar-Ilan University, Ramat-Gan 5290002, Israel.

出版信息

Int J Mol Sci. 2021 Dec 21;23(1):43. doi: 10.3390/ijms23010043.

Abstract

Virtual screening (VS) is a well-established method in the initial stages of many drug and material design projects. VS is typically performed using structure-based approaches such as molecular docking, or various ligand-based approaches. Most docking tools were designed to be as global as possible, and consequently only require knowledge on the 3D structure of the biotarget. In contrast, many ligand-based approaches (e.g., 3D-QSAR and pharmacophore) require prior development of project-specific predictive models. Depending on the type of model (e.g., classification or regression), predictive ability is typically evaluated using metrics of performance on either the training set (e.g.,QCV2) or the test set (e.g., specificity, selectivity or QF1/F2/F32). However, none of these metrics were developed with VS in mind, and consequently, their ability to reliably assess the performances of a model in the context of VS is at best limited. With this in mind we have recently reported the development of the enrichment optimization algorithm (EOA). EOA derives QSAR models in the form of multiple linear regression (MLR) equations for VS by optimizing an enrichment-based metric in the space of the descriptors. Here we present an improved version of the algorithm which better handles active compounds and which also takes into account information on inactive (either known inactive or decoy) compounds. We compared the improved EOA in small-scale VS experiments with three common docking tools, namely, Glide-SP, GOLD and AutoDock Vina, employing five molecular targets (acetylcholinesterase, human immunodeficiency virus type 1 protease, MAP kinase p38 alpha, urokinase-type plasminogen activator, and trypsin I). We found that EOA consistently outperformed all docking tools in terms of the area under the ROC curve (AUC) and EF metrics that measured the overall and initial success of the VS process, respectively. This was the case when the docking metrics were calculated based on a consensus approach and when they were calculated based on two different sets of single crystal structures. Finally, we propose that EOA could be combined with molecular docking to derive target-specific scoring functions.

摘要

虚拟筛选(VS)是许多药物和材料设计项目初始阶段的一种成熟方法。VS 通常使用基于结构的方法(如分子对接)或各种基于配体的方法来进行。大多数对接工具的设计尽可能具有全局适用性,因此只需要了解生物靶标的 3D 结构。相比之下,许多基于配体的方法(例如 3D-QSAR 和药效团)需要预先开发针对特定项目的预测模型。根据模型的类型(例如分类或回归),预测能力通常使用训练集(例如 QCV2)或测试集(例如特异性、选择性或 QF1/F2/F32)上的性能指标进行评估。然而,这些指标都不是为 VS 而开发的,因此,它们在 VS 背景下可靠评估模型性能的能力充其量是有限的。考虑到这一点,我们最近报告了富集优化算法(EOA)的开发。EOA 通过在描述符空间中优化基于富集的度量标准,以多元线性回归(MLR)方程的形式为 VS 生成 QSAR 模型。在这里,我们提出了一种改进的算法版本,该版本更好地处理活性化合物,并考虑了非活性(已知非活性或诱饵)化合物的信息。我们在小规模 VS 实验中比较了改进的 EOA 与三种常见的对接工具,即 Glide-SP、GOLD 和 AutoDock Vina,使用了五个分子靶标(乙酰胆碱酯酶、人类免疫缺陷病毒 1 型蛋白酶、MAP 激酶 p38α、尿激酶型纤溶酶原激活物和胰蛋白酶 I)。我们发现,EOA 在衡量 VS 过程整体和初始成功的 AUC 和 EF 指标方面,始终优于所有对接工具。当基于共识方法计算对接指标时,以及当基于两个不同的单晶结构集计算对接指标时,都是如此。最后,我们提出 EOA 可以与分子对接相结合,以衍生出针对特定靶标的评分函数。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bff/8744642/e6d3b3e95c67/ijms-23-00043-g001a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验